Skip to main content
Top
Published in: International Urology and Nephrology 1/2008

01-03-2008 | Original Article

Effects of wortmannin on phosphorylation of PDK1, GSK3-β, PTEN and expression of Skp2 mRNA after ischemia/reperfusion injury in the mouse kidney

Authors: Xiangyi Zheng, Liping Xie, Jie Qin, Huafeng Shen, Zhaodian Chen, Yongfeng Jin

Published in: International Urology and Nephrology | Issue 1/2008

Login to get access

Abstract

Aim

The aim of this study was to investigate the role of 3-phosphoinositide-dependent protein kinase-1 (PDK1), glycogen synthase kinase-3β (GSK3-β) and phosphatase and tensin homologue deleted on chromosome 10 (PTEN), which are the components of the phosphoinositide 3-kinase (PI3K)/Akt pathway, and expression of S-phase kinase-associated protein 2 (Skp2) messenger RNA (mRNA) in renal ischemia/reperfusion.

Materials and methods

Three experimental groups, sham-operative mice, vehicle-delivered mice and wortmannin-treated ischemia/reperfusion injury (IRI) mice were designed to examine PDK1, GSK3-β and PTEN phosphorylation status, as well as expression of Skp2 mRNA at 30 min, 90 min, 24 h and 48 h of reperfusion after ischemia treatment. Wortmannin or its vehicle was given intraperitoneally 4 h before surgery. Expression of Skp2 mRNA was examined by semiquantitative reverse-transcription PCR, and the components of the PI3K/Akt pathway were detected by western blotting in the IRI kidney.

Results

Phosphorylation of PDK1(Ser241), GSK3-β(Ser9) and PTEN(Ser380) was increased after ischemia/reperfusion in the mouse kidney, and phosphorylation of PDK1 was reduced by wortmannin administration. The renal Skp2 mRNA increased after IRI in mouse, which could be inhibited by wortmannin.

Conclusions

Our primary study suggests that the PI3K/Akt signaling pathway plays an important role in regulating the repair following renal IRI. The Skp2 mRNA increased in the IRI kidney and may be regulated by the PI3K/Akt pathway.
Literature
1.
go back to reference Edelstein CL, Ling H, Wangsiripaisan A, Schrier RW (1997) Emerging therapies for acute renal failure. Am J Kidney Dis 30:S89–S95PubMed Edelstein CL, Ling H, Wangsiripaisan A, Schrier RW (1997) Emerging therapies for acute renal failure. Am J Kidney Dis 30:S89–S95PubMed
2.
go back to reference Kelly KJ, Molitoris BA (2000) Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20:4–19PubMed Kelly KJ, Molitoris BA (2000) Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20:4–19PubMed
3.
go back to reference Harris TK (2003) PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design. IUBMB Life 55:117–126PubMedCrossRef Harris TK (2003) PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design. IUBMB Life 55:117–126PubMedCrossRef
4.
go back to reference Andreucci M, Michael A, Kramers C et al (2003) Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int 64:1189–1198PubMedCrossRef Andreucci M, Michael A, Kramers C et al (2003) Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int 64:1189–1198PubMedCrossRef
5.
go back to reference Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253:210–229PubMedCrossRef Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253:210–229PubMedCrossRef
6.
go back to reference Brunet A, Bonni A, Zigmond MJ et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857–868PubMedCrossRef Brunet A, Bonni A, Zigmond MJ et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857–868PubMedCrossRef
7.
go back to reference Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267PubMedCrossRef Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–267PubMedCrossRef
9.
go back to reference Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599–602PubMedCrossRef Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599–602PubMedCrossRef
10.
go back to reference Franke TF, Yang SI, Chan TO et al (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727–736PubMedCrossRef Franke TF, Yang SI, Chan TO et al (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727–736PubMedCrossRef
11.
13.
go back to reference Shibata M, Yamawaki T, Sasaki T et al (2002) Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res 942:1–10PubMedCrossRef Shibata M, Yamawaki T, Sasaki T et al (2002) Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res 942:1–10PubMedCrossRef
14.
go back to reference Matsui T, Tao J, del Monte F et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330–335PubMed Matsui T, Tao J, del Monte F et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330–335PubMed
15.
go back to reference Xie LP, Zheng XY, Qin J et al (2006) Role of PI3-kinase/Akt signaling pathway in renal function and cell proliferation after renal ischemia/reperfusion injury in mice. Nephrology 11:207–212PubMedCrossRef Xie LP, Zheng XY, Qin J et al (2006) Role of PI3-kinase/Akt signaling pathway in renal function and cell proliferation after renal ischemia/reperfusion injury in mice. Nephrology 11:207–212PubMedCrossRef
16.
go back to reference Takaoka M, Itoh M, Hayashi S, Kuro T, Matsumura Y (1999) Proteasome participates in the pathogenesis of ischemic acute renal failure in rats. Eur J Pharmacol 384:43–46PubMedCrossRef Takaoka M, Itoh M, Hayashi S, Kuro T, Matsumura Y (1999) Proteasome participates in the pathogenesis of ischemic acute renal failure in rats. Eur J Pharmacol 384:43–46PubMedCrossRef
17.
go back to reference Itoh M, Takaoka M, Shibata A, Ohkita M, Matsumura Y (2001) Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 298:501–507PubMed Itoh M, Takaoka M, Shibata A, Ohkita M, Matsumura Y (2001) Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 298:501–507PubMed
18.
go back to reference Zhang H, Kobayashi R, Galaktionov K, Beach D (1995) p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82:915–925PubMedCrossRef Zhang H, Kobayashi R, Galaktionov K, Beach D (1995) p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82:915–925PubMedCrossRef
19.
go back to reference Schulman BA, Carrano AC, Jeffrey PD et al (2000) Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408:381–386PubMedCrossRef Schulman BA, Carrano AC, Jeffrey PD et al (2000) Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408:381–386PubMedCrossRef
20.
go back to reference Singh VP, Saluja AK, Bhagat L et al (2001) Phosphatidylinositol 3-kinase -dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 108:1387–1395PubMed Singh VP, Saluja AK, Bhagat L et al (2001) Phosphatidylinositol 3-kinase -dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 108:1387–1395PubMed
21.
go back to reference Muller C, Dunschede F, Koch E, Vollmar AM, Kiemer AK (2003) Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 285:G769–778PubMed Muller C, Dunschede F, Koch E, Vollmar AM, Kiemer AK (2003) Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 285:G769–778PubMed
22.
go back to reference Matsui T, Li L, Wu JC et al (2002) Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277:22896–22901PubMedCrossRef Matsui T, Li L, Wu JC et al (2002) Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277:22896–22901PubMedCrossRef
23.
go back to reference Loverre A, Ditonno P, Crovace A et al (2004) Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15:2675–2686PubMedCrossRef Loverre A, Ditonno P, Crovace A et al (2004) Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15:2675–2686PubMedCrossRef
24.
go back to reference Lieberthal W, Fuhro R, Andry CC et al (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693–706PubMed Lieberthal W, Fuhro R, Andry CC et al (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693–706PubMed
25.
go back to reference Smith KD, Wrenshall LE, Nicosia RF et al (2003) Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 14:1037–1045PubMedCrossRef Smith KD, Wrenshall LE, Nicosia RF et al (2003) Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 14:1037–1045PubMedCrossRef
26.
go back to reference Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346(Pt 3):561–576PubMedCrossRef Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346(Pt 3):561–576PubMedCrossRef
27.
go back to reference Kis A, Yellon DM, Baxter GF (2003) Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. Mol Cell Cardiol 35:1063–1071CrossRef Kis A, Yellon DM, Baxter GF (2003) Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. Mol Cell Cardiol 35:1063–1071CrossRef
28.
go back to reference Budas GR, Sukhodub A, Alessi DR, Jovanovic A (2006) 3′Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J 20:2556–2558PubMedCrossRef Budas GR, Sukhodub A, Alessi DR, Jovanovic A (2006) 3′Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J 20:2556–2558PubMedCrossRef
29.
go back to reference Gross ER, Hsu AK, Gross GJ (2004) Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94:960–966PubMedCrossRef Gross ER, Hsu AK, Gross GJ (2004) Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94:960–966PubMedCrossRef
30.
go back to reference Nishihara M, Miura T, Miki T et al (2006) Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 291:H748–755PubMedCrossRef Nishihara M, Miura T, Miki T et al (2006) Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 291:H748–755PubMedCrossRef
31.
go back to reference Omori N, Jin G, Li F et al (2002) Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain Res 954:317–322PubMedCrossRef Omori N, Jin G, Li F et al (2002) Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain Res 954:317–322PubMedCrossRef
32.
go back to reference Cai Z, Semenza GL (2005) PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 97:1351–1359PubMedCrossRef Cai Z, Semenza GL (2005) PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 97:1351–1359PubMedCrossRef
33.
go back to reference Bonventre JV (2003) Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14(Suppl 1):S55–61PubMedCrossRef Bonventre JV (2003) Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14(Suppl 1):S55–61PubMedCrossRef
34.
go back to reference Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193–199PubMedCrossRef Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1:193–199PubMedCrossRef
35.
go back to reference Bornstein G, Bloom J, Sitry-Shevah D et al (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278:25752–25757PubMedCrossRef Bornstein G, Bloom J, Sitry-Shevah D et al (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 278:25752–25757PubMedCrossRef
36.
go back to reference Bouscary D, Pene F, Claessens YE et al (2003) Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 101:3436–3443PubMedCrossRef Bouscary D, Pene F, Claessens YE et al (2003) Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 101:3436–3443PubMedCrossRef
Metadata
Title
Effects of wortmannin on phosphorylation of PDK1, GSK3-β, PTEN and expression of Skp2 mRNA after ischemia/reperfusion injury in the mouse kidney
Authors
Xiangyi Zheng
Liping Xie
Jie Qin
Huafeng Shen
Zhaodian Chen
Yongfeng Jin
Publication date
01-03-2008
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2008
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-007-9215-9

Other articles of this Issue 1/2008

International Urology and Nephrology 1/2008 Go to the issue

Commentary

Reply

Acknowledgments

Reviewers 2007

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.